A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Phase of Trial: Phase III
Latest Information Update: 17 Sep 2019
Price : $35 *
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Enterovirus infections; Rhinorrhoea; Rhinovirus infections
- Focus Registrational; Therapeutic Use
- Sponsors Romark Laboratories
- 04 Apr 2019 Status changed from recruiting to completed.
- 17 Dec 2018 Planned number of patients changed from 1200 to 1750.
- 28 Sep 2018 Status changed from not yet recruiting to recruiting.